Therefore, upregulation of the activity and level of NEP in the brains of AD patients may attenuate Aβ peptide accumulation, protect neurons against Aβ toxicity, and help inhibit cognitive deficits as well as Aβ-related synaptic loss [10]. This evidence concerns the gene MME and Alzheimer disease.